Navigation Links
Renowned Operations and Supply Chain Expert Dr. David Simchi-Levi Joins OPS Rules
Date:7/2/2012

Waltham, Massachusetts (PRWEB) July 02, 2012

OpsRules Partners, LLC., a leading operations strategy consulting firm, today announced that Dr. David Simchi-Levi, world renowned supply chain expert, has joined the company as chairman.

Dr. David Simchi-Levi is an Engineering Systems professor at MIT and the co-founder of LogicTools, a supply chain software company that is now part of IBM. He has extensive experience both on the academic and the business sides of operations and supply chain management and is considered a leader in these fields.

His most recent book “Operations Rules: Delivering customer value through flexible operations” has been praised by business executives. The book addresses the current business concerns around Complexity Management, Flexibility, Segmentation and Supply Chain Risk Management. Dr. Simchi-Levi identifies the crucial element in a company's success: the link between the values it provides its customers and its operations strategies. Most importantly, he offers a set of scientifically and empirically-based rules that management can follow to achieve a quantum leap in operations performance.

Indeed, Professor Simchi-Levi's recent work with companies such as Cisco, Dell Computers and Pepsi Beverage Company, to name a few, underscores the impact of effective implementation of concepts such as supply chain flexibility, segmentation and complexity reduction on the firm's bottom line.

“There are many opportunities to achieve improved performance through better understanding of the basic drivers of operations” stated Dr. Simchi-Levi “I am excited to join OPS Rules and implement the many concepts and ideas that I have developed over many years. The opportunity to work with a team of professionals in order to delve into a company’s specific challenges, analyze its data and come up with innovative solutions that help it thrive is what drives me to start this new endeavor.”

Mike Romeri, OPS Rules Managing Partner observed “We are delighted that Dr. Simchi-Levi is joining us. Together we can achieve transformational thinking and develop intellectual property that enables and drives significant changes in strategy to improve customer value and reduce operational costs and risk.”

About OPS Rules
OPS Rules is a leading operations strategy consulting company with capable partners and associates who provide expertise, distinctive viewpoints and reputation for developing and implementing new ideas with leading companies. We take an analytical approach that is fact-based and data-driven that leads to recommendations and innovations that are followed through to successful implementations. We employ a flexible transformation approach that ensures successful adoption of essential new skills.

Contact: press(at)opsrules(dot)com or (855)677-7853

Read the full story at http://www.prweb.com/releases/2012/7/prweb9657991.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
2. Amarillo Biosciences Announces Plan to Open Asia Operations Center in Taipei, Taiwan
3. NanoLogix Provides Testing and Operations Update
4. Hospira Names John B. Elliot Senior Vice President of Operations
5. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
6. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
7. Vermillion Sharpens Focus and Streamlines Operations in 2012
8. StemCyte Adds World Class Talent to its North America and Global Operations
9. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
10. inVentiv Health Selected to Provide Sales Operations Support for Santarus
11. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... United States multicenter, prospective clinical study that demonstrates the accuracy of the ... of identifying clinically significant acute bacterial and viral respiratory tract infections by ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
Breaking Biology Technology:
(Date:8/15/2017)...   ivWatch LLC , a medical device company focused on ... receipt of its ISO 13485 Certification, the global standard for medical ... Standardization (ISO®). ... Continuous Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as ...
(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
Breaking Biology News(10 mins):